Medicare Enrolled

Dr. Joel Holiner, M.D.

Addiction Psychiatry Physician · Dallas, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
7777 FOREST LN, Dallas, TX 75230
9725664591
Registered in NPPES since 2005
NPI: 1639174246 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Holiner from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Holiner? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Holiner

Dr. Joel Holiner is an addiction psychiatry physician in Dallas, TX, with 21 years of NPI registration. Based on federal Medicare data, Dr. Holiner performed 3,352 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Holiner received a total of $796,694 from 44 pharmaceutical and/or device companies across 1689 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Holiner is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years of NPI registration ▲ Top 7% volume in TX $796,694 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
3,352
Medicare services
Top 7% in TX for addiction psychiatry physician
Not available
Unique patients (not deduplicated)
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
2,378 $92 $175
Psychotherapy and evaluation, 30 minutes
A combined session involving psychotherapy and an evaluation and management visit lasting 30 minutes.
681 $55 $101
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
93 $63 $139
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
83 $54 $95
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
73 $133 $225
Psychiatric diagnostic evaluation with medical services
A psychiatric assessment that includes medical services to evaluate mental health conditions.
44 $137 $340
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$796,694
Total received (2018-2024)
Avg $113,813/year across 7 years
Top 3% in TX for addiction psychiatry physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
1,689
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$227,589
2023
$199,609
2022
$122,552
2021
$83,594
2020
$47,617
2019
$50,676
2018
$65,058

Payments by company (2024)

Teva Pharmaceuticals USA, Inc.
$74,206
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$60,872
Axsome Therapeutics, Inc.
$33,388
Supernus Pharmaceuticals, Inc.
$25,714
Alkermes, Inc.
$10,193
Noven Pharmaceuticals, Inc.
$9,834
Tris Pharma Inc
$8,227
Corium, LLC
$2,989
E.R. Squibb & Sons, L.L.C.
$621
ABBVIE INC.
$461
Janssen Pharmaceuticals, Inc
$372
Otsuka Pharmaceutical Development & Commercialization, Inc.
$351
Lundbeck LLC
$139
Indivior Inc.
$54
Otsuka America Pharmaceutical, Inc.
$46
Almatica Pharma LLC
$40
Neurocrine Biosciences, Inc.
$30
Bausch Health US, LLC
$18
LivaNova USA, Inc.
$18
Tempus AI, Inc
$16
Top 3 companies account for 74.0% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$232,310
ITI, Inc.
$185,259
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$60,872
Alkermes, Inc.
$60,361
Supernus Pharmaceuticals, Inc.
$56,086
Axsome Therapeutics, Inc.
$52,844
Eisai Inc.
$29,796
Neurocrine Biosciences, Inc.
$23,933
Tris Pharma Inc
$17,506
Otsuka America Pharmaceutical, Inc.
$17,402
Noven Pharmaceuticals, Inc.
$9,930
Corium, LLC
$9,452
Otsuka Pharmaceutical Development & Commercialization, Inc.
$8,841
IDORSIA PHARMACEUTICALS US INC
$8,113
Sunovion Pharmaceuticals Inc.
$6,925
Janssen Pharmaceuticals, Inc
$5,280
Allergan Inc.
$3,252
Indivior Inc.
$2,344
Neuronetics, Inc.
$1,269
ABBVIE INC.
$1,032
E.R. Squibb & Sons, L.L.C.
$621
Lundbeck LLC
$459
AbbVie Inc.
$427
Allergan, Inc.
$290
Ironshore Pharmaceuticals Inc.
$279
JAZZ PHARMACEUTICALS INC.
$267
Janssen Scientific Affairs, LLC
$210
Shire North American Group Inc
$197
Neos Therapeutics, LP
$178
Vanda Pharmaceuticals Inc.
$169
Sumitomo Pharma America, Inc.
$131
LivaNova USA, Inc.
$114
Boehringer Ingelheim Pharmaceuticals, Inc.
$106
Rhodes Pharmaceuticals L.P.
$97
Merck Sharp & Dohme LLC
$75
Kaleo, Inc.
$68
Almatica Pharma LLC
$40
Merck Sharp & Dohme Corporation
$39
Takeda Pharmaceuticals U.S.A., Inc.
$32
Orexo US, Inc.
$20
ARBOR PHARMACEUTICALS, INC.
$18
Bausch Health US, LLC
$18
Tempus AI, Inc
$16
Avanir Pharmaceuticals, Inc.
$12
Top 3 companies account for 60.1% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ABILIFY MYCITE · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Aptensio XR · Aristada 441 mg · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · CAPLYTA · COBENFY · COPAXONE · Dayvigo · Dyanavel XR · EVZIO · Evekeo · Fanapt · HETLIOZ · INGREZZA · INVEGA SUSTENNA · INVEGA TRINZA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LONHALA MAGNAIR · LOREEV XR · LYBALVI · MYDAYIS · NEUROSTAR TMS THERAPY · NEUROSTAR TMS THERAPY SYSTEM · NUEDEXTA · Onyda XR · PERSERIS · QELBREE · QUVIVIQ · Qelbree · Quillichew ER · Quillivant · REXULTI · SPRAVATO · SUBLOCADE · SUNOSI · TRINTELLIX · UZEDY · VNS THERAPY SYMMETRY MODEL 8103 GENERATOR · VNS Therapy · VRAYLAR · VYVANSE · WELLBUTRIN · Xelstrym · Zubsolv
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an addiction psychiatry physician in Dallas?
Compare addiction psychiatry physicians in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse addiction psychiatry physicians nearby

Geographic Context

Addiction psychiatry physicians in nearby ZIP areas
17
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
MEDICAL CITY DALLAS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Holiner is a clinical cardiology specialist, with above-average Medicare volume (top 7% in TX), with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Holiner experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Holiner performed 2,378 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Holiner receive payments from pharmaceutical companies?
Yes. Dr. Holiner received a total of $796,694 from 44 companies across 1,689 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Holiner's costs compare to other addiction psychiatry physicians in Dallas?
Dr. Holiner's average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Holiner) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →